Dr. Tara Brooke Kelley Gregory, MD

Dr. Gregory practices at HealthONE Clinic Services - Oncology Hematology in Denver, Colorado.

Dr. Gregory's NPI, 1407973993, was assigned on March 22, 2007. Dr. Gregory graduated from College of Medicine - Tucson in 2004. Dr. Gregory holds Colorado license 47002.

Dr. Gregory's primary practice is HealthONE Clinic Services - Oncology Hematology, at 1721 E 19th Ave, Denver, CO 80218 in Denver County. The practice phone is (720) 754-4800.

Dr. Gregory's primary practice is HealthONE Clinic Services - Oncology Hematology in Denver, Colorado. Dr. Gregory is also affiliated with HCA HealthONE Presbyterian St. Luke's. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. Gregory to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gregory practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gregory's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gregory is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Gregory's licenses on file in 3 states: Colorado, Arizona and New Mexico.

Dmand AI lists chronic leukemia, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Gregory treats.

CMS data shows 9,531 Medicare services from Dr. Gregory across 14 procedure codes in 2024, for 250 Medicare patients. Medicare paid $358,352 for them. Every service was in an office.

CMS counts 250 Medicare patients who saw Dr. Gregory in 2024. The largest group is 65 to 74, with 150 patients. 68% of them have high cholesterol, and 66% have high blood pressure. 9% are also on Medicaid. Their average risk score is 2.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gregory's median patient age at 68, with 48% women.

In 2024, Dr. Gregory wrote 1,487 Medicare Part D claims for 112 patients. 79% of them were for generic drugs. CMS names the drug for 1,122 of them, across 39 drugs with 11 or more claims each, at $3,750,781 in total drug cost. In 2023, CMS named 749 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Gregory for performance year 2024, reported as part of a group. Dr. Gregory accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gregory as offering telehealth.

Dmand AI links 12 papers to Dr. Gregory, published from 2009 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Hematopoietic Stem Cell Transplantation, Multiple Myeloma and Antineoplastic Combined Chemotherapy Protocols. Dr. Gregory has published most often in Transplant Cell Ther. Dr. Gregory's most frequent co-authors are Navneet Singh Majhail, MD, Jesus G. Berdeja, MD and Vikas Bhushan, MD.

Dmand AI links Dr. Gregory to 10 clinical trials, 4 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Graft vs Host Disease, Immunoglobulin Light-chain Amyloidosis and Multiple Myeloma. Prothena Biosciences Ltd. sponsors the most, 2.

CMS Open Payments shows 357 general payments to Dr. Gregory from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Amgen Inc. paid the most, $54,397.

Dr. Gregory graduated from College of Medicine - Tucson in 2004.

Dr. Gregory is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.